Exhibit 99.1 Proxy

SPECIAL MEETING OF MEMBERS OF MOLECULAR PHARMACOLOGY (USA) LIMITED TO BE HELD AT 618 - 688 WEST HASTINGS STREET, VANCOUVER, BC ON APRIL 21 , 2006, AT 2:00 PM PACIFIC STANDARD TIME. The undersigned member ("Registered Shareholder") of the Corporation hereby appoints, Ian Downs, a Director of the Corporation, or failing this person, Jeffrey Edwards, a Director of the Corporation, or in the place of the foregoing, ______________________________ as proxyholder for and on behalf of the Registered Shareholder with the power of substitution to attend, act and vote for and on behalf of the Registered Shareholder in respect of all matters that may properly come before the Meeting of the Registered Shareholders of the Corporation and at every adjournment thereof, to the same extent and with the same powers as if the undersigned Registered Shareholder were present at the said Meeting, or any adjournment thereof. The Registered Shareholder hereby directs the proxyholder to vote the securities of the Corporation registered in the name of the Registered Shareholder as specified herein.	Resolutions (For full detail of each item, please see the enclosed Notice of Meeting and Information Circular)
					For	Against
		1.	To approve the acquisition of all the shares of Molecular Pharmacology Limited an Australian corporation from Pharmanet Group Limited on the terms described in the Information Statement dated March 10 , 2006		______	______
		1.
		2.	To approve the amendment of the Articles of Incorporation to:		______	______
			a.	expressly opt-out of, or elect not to be governed by the "Acquisition of Controlling Interest" provisions contained in NRS Sections 78.378 through 78.3793 inclusive all as permitted under NRS Section 78.378.1; and
			b.	expressly opt-out of, and elect not to be governed by the "Combinations with Interested Stockholders" provisions contained in NRS Section 78.411 through 78.444, inclusive all as permitted under NRS Section 78.434
		3.	To adopt the 2006 Stock Option Plan on the terms described in the Information Statement dated March 10 , 2006.		______	______
		4.	To transact such other business as may properly come before the Meeting		______	______

	The undersigned Registered Shareholder hereby revokes any proxy previously given to attend and vote at said Meeting.
	SIGN HERE:		_______________________________
	Please Print Name:		_________________________________________________
	Date:		_________________________________________________
	Number of Shares Represented by Proxy:		_________________________________________________

	*THIS PROXY FORM IS NOT VALID UNLESS IT IS SIGNED AND DATED.* *SEE IMPORTANT INFORMATION AND INSTRUCTIONS ON REVERSE*

1.	This Proxy is solicited by the Management of the Corporation.
2.	This form of proxy ("Instrument of Proxy") must be signed by you, the Registered Shareholder, or by your attorney duly authorized by you in writing, or, in the case of a corporation, by a duly authorized officer or representative of the corporation; and if executed by an attorney, officer, or other duly appointed representative, the original or a notarial copy of the instrument so empowering such person, or such other documentation in support as shall be acceptable to the Chairman of the Meeting, must accompany the Instrument of Proxy.
3.	If this Instrument of Proxy is not dated in the space provided, authority is hereby given by you, the Registered Shareholder, for the proxyholder to date this proxy seven (7) calendar days after the date on which it was mailed to you, the Registered Shareholder, by Molecular Pharmacology (USA) Limited.
4.	A Registered Shareholder who wishes to attend the Meeting and vote on the resolutions in person, may simply register with the scrutineers before the Meeting begins.
5.	A Registered Shareholder who is not able to attend the Meeting in person but wishes to vote on the resolutions, may do the following:
	(a)	(a) appoint one of the management proxyholders named on the Instrument of Proxy, by leaving the wording appointing a nominee as is (i.e. do not strike out the management proxyholders shown and do not complete the blank space provided for the appointment of an alternate proxyholder). Where no choice is specified by a Registered Shareholder with respect to a resolution set out in the Instrument of Proxy, a management appointee acting as a proxyholder will vote in favour of each matter identified on this Instrument of Proxy and for the nominees of management for directors and auditor as identified in this Instrument of Proxy;
	OR
	(b)	**(b) appoint another proxyholder,** who need not be a Registered Shareholder of the Corporation, to vote according to the Registered Shareholder's instructions, by striking out the management proxyholder names shown and inserting the name of the person you wish to represent you at the Meeting in the space provided for an alternate proxyholder. If no choice is specified, the proxyholder has discretionary authority to vote as the proxyholder sees fit.
6.	The securities represented by this Instrument of Proxy will be voted or withheld from voting in accordance with the instructions of the Registered Shareholder on any poll of a resolution that may be called for and, if the Registered Shareholder specifies a choice with respect to any matter to be acted upon, the securities will be voted accordingly. Further, the securities will be voted by the appointed proxyholder with respect to any amendments or variations of any of the resolutions set out on the Instrument of Proxy or matters which may properly come before the Meeting as the proxyholder in its sole discretion sees fit.

If a Registered Shareholder has submitted an Instrument of Proxy, the Registered Shareholder may still attend the Meeting and may vote in person. To do so, the Registered Shareholder must record his/her attendance with the scrutineers before the commencement of the Meeting and revoke, in writing, the prior votes.